Therapeutic Effect of Acupoint Injection with Nucleotide Plus Conventional Western Medicine Treament for Moderate and Severe Chronic Obstructive Pulmonary Disease
10.13359/j.cnki.gzxbtcm.2017.02.013
- VernacularTitle:核酪穴位注射对中重度慢性阻塞性肺疾病疗效的影响
- Author:
Jiayi DONG
;
Baohong LI
;
Xiaoping TONG
;
Ling LIN
;
Yu XIE
- Keywords:
pulmonary disease,chronic obstructive;
nucleotide;
acupoint injection;
Dingchuan(EX-B1)
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2017;34(2):201-204
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the therapeutic effect of acupoint injection with nucleotide plus conventional western medicine treatment for moderate and severe chronic obstructive pulmonary disease (COPD).Methods Sixty patients confirmed as moderate and severe COPD were evenly randomized into treatment group and control group.The treatment group was given conventional western medicine treatment and injection with nucleotide on bilateral Dingchuan points,and the control group was given conventional western medicine treatment alone.The treatment lasted for one year.The frequency of COPD acute onset and hospitalization times within one year were recorded.Meanwhile,the severity of dyspnea was evaluated with Medical Research Council (MRC) dyspnea scale scoring.Results (1)The frequency of COPD acute onset and hospitalization times within one year in the treatment group were lowered,and the differences were significant compared with those in the control group (P ＜ 0.05 or P ＜ 0.01).(2) After treatment,MRC dyspnea scale scores in the treatment group were improved (P ＜ 0.05 compared with those before treatment),but the improvement of the scores was insignificant in the control group(P ＞ 0.05).The intergroup comparison showed that the effect on improving MRC dyspnea scale scores in the treatment group was superior to that in the control group (P ＜ 0.05),indicating that the severity of dyspnea was much improved in the treatment group as compared with the control group.Conclusion Acupoint injection with nucleotide is effective on enhancing the therapeutic effect of conventional western medicine treatment for moderate and severe COPD.
